Literature DB >> 26210064

Drug-induced status epilepticus.

Hannah R Cock1.   

Abstract

Drug-induced status epilepticus (SE) is a relatively uncommon phenomenon, probably accounting for less than 5% of all SE cases, although limitations in case ascertainment and establishing causation substantially weaken epidemiological estimates. Some antiepileptic drugs, particularly those with sodium channel or GABA(γ-aminobutyric acid)-ergic properties, frequently exacerbate seizures and may lead to SE if used inadvertently in generalized epilepsies or less frequently in other epilepsies. Tiagabine seems to have a particular propensity for triggering nonconvulsive SE sometimes in patients with no prior history of seizures. In therapeutic practice, SE is most commonly seen in association with antibiotics (cephalosporins, quinolones, and some others) and immunotherapies/chemotherapies, the latter often in the context of a reversible encephalopathy syndrome. Status epilepticus following accidental or intentional overdoses, particularly of antidepressants or other psychotropic medications, has also featured prominently in the literature: whilst there are sometimes fatal consequences, this is more commonly because of cardiorespiratory or metabolic complications than as a result of seizure activity. A high index of suspicion is required in identifying those at risk and in recognizing potential clues from the presentation, but even with a careful analysis of patient and drug factors, establishing causation can be difficult. In addition to eliminating the potential trigger, management should be as for SE in any other circumstances, with the exception that phenobarbitone is recommended as a second-line treatment for suspected toxicity-related SE where the risk of cardiovascular complications is higher anyways and may be exacerbated by phenytoin. There are also specific recommendations/antidotes in some situations. The outcome of drug-induced status epilepticus is mostly good when promptly identified and treated, though less so in the context of overdoses. This article is part of a Special Issue entitled "Status Epilepticus".
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic; Antidepressant; Drug-induced seizure; Overdose; Status epilepticus; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26210064     DOI: 10.1016/j.yebeh.2015.04.034

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

1.  Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?

Authors:  Kousuke Kanemoto
Journal:  Curr Top Behav Neurosci       Date:  2022

2.  Carbamazepine-induced convulsive status epilepticus in benign adult familial myoclonic epilepsy: a case report.

Authors:  Tatsuya Ueno; Atsuko Katagai; Rena Okudera; Masako Fujita; Masahiko Tomiyama
Journal:  Neurol Sci       Date:  2022-08-31       Impact factor: 3.830

3.  Paradoxical Anticonvulsant Effect of Cefepime in the Pentylenetetrazole Model of Seizures in Rats.

Authors:  Dmitry V Amakhin; Ilya V Smolensky; Elena B Soboleva; Aleksey V Zaitsev
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-26

4.  Acute symptomatic seizure due to tacrolimus-related encephalopathy after liver transplantation: two case reports.

Authors:  Yao Li; Haijiu Wang; Dongdong Han; Zhixin Wang; Li Zhang; Shiwei Yang; Qiang Wang; Hao Wen; Haining Fan
Journal:  J Int Med Res       Date:  2019-11-10       Impact factor: 1.671

Review 5.  Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Zhuo Wang; Munan Zhao; Sujun Gao
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.